Sage Therapeutics (SAGE) PT Raised to $30 at BofA Securities
Tweet
Share
E-mailGet Alerts SAGE Hot Sheet
Price: $8.68 --0%
Rating Summary:
3 Buy, 25 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
3 Buy, 25 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
BofA Securities analyst Tazeen Ahmad raised the price target on Sage Therapeutics (NASDAQ: SAGE) to $30.00 (from $26.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Meridian Mining Plc (MNO:CN) PT Raised to GBP3.75 at BMO Capital
- Okta, Inc (OKTA) PT Raised to $230 at BMO Capital on 'AI and Virtuous Cycle Opportunity'
- Infosys Ltd. (INFO:IN) (INFY) PT Lowered to INR1,430 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
